REGISTER now: Visser ai webinar - BEYOND THE HYPE: AI IN PATENT PROSECUTION
​

UKIPO report of IP trends for UK Higher Education Institutions highlights life sciences innovation

No items found.
​
April 30, 2020
Additional information
Chevron icon
Info
Tags
Life
Table of contents
Chevron icon
Table of contents
  • Toc Heading
  • Toc Heading

On 29 April 2020, the UKIPO published an overview report of IP trends for UK Higher Education Institutions (HEIs) and their spin-out businesses, between 1999 and 2018. We focus on some of the main takeaways and trends from this overview for the life sciences sector below.

The report highlights the value that UK universities place on life sciences innovation, as reflected by the impressive percentage of patent publications in the fields of Biotechnology and Pharmaceuticals. Indeed, 47 % of UK HEI patent publications are in the Chemistry sector (over 50% of which used pharmaceuticals and biotechnology IPC technology fields), compared to 21% of all patent publications globally.

Notably, there was a rise in the level of international collaboration between UK HEIs and entities abroad, particularly in the US. This trend demonstrates both the aim of universities to more effectively exploit their IP commercially and the importance of collaboration for the transfer of technology.

Life sciences powerhouses Imperial College London, UCL and Oxford University were among those institutions showing not only the largest output of published applications, but also the greatest proportional increase in activity. Furthermore, of the top 10 spin-out businesses, according to the number of applications, six of these have a biotechnological focus, including DNA sequencing products, biotherapeutics and drug discovery.

The importance of innovation within the life sciences sector to UK universities, and the UK as a whole, is clear from this report. As we move into the era of personalised medicine and with Artificial Intelligence and machine learning becoming increasingly significant in healthcare innovation, it will be interesting to see whether UK HEIs continue to lead in this new era and whether more and more computer technology related patent filings over the next 20 years will be important to the healthcare sector.

Recent Case Reports

See all Case Reports

Invalidity of juicer patent upheld on appeal
03 November 2026
The Court of Appeal upheld the invalidity of Hurom’s juicer patent for lack of inventive step, while clarifying the admissibility requirements for patent amendments and the use of the unamended description when construing amended claims. It also confirmed the UPC’s jurisdiction over infringement in Poland despite Poland not being a UPCA Contracting Member State, but found that Hurom had failed to establish infringement under Polish law.
​
Evidence preservation doesn’t stretch to interrogation
03 November 2026
The Court of Appeal confirmed that evidence-preservation orders may be granted ex parte where there is a demonstrable risk that evidence could be destroyed or become unavailable, and that such orders may extend to relevant commercial and promotional documents. However, Art. 60 UPCA does not permit a bailiff or expert to question the defendant’s personnel on substantive technical matters, which must instead be handled under the Court’s control.
​
UPC Court of Appeal clarifies claim construction, the role of party experts, and provisional measures in direct-competition cases
03 November 2026
The CoA’s decision of 30 April 2025 in Insulet v EOFlow provides important guidance on claim construction, the role of party-appointed experts and the requirements for provisional injunctions.
​